We showed that IFNα-2a or IFNγ-1b themselves are potently anti-neoplastic in vitro and in mouse models of ovarian cancer, and the effect was amplified with the addition of monocytes [8]. The gene discussed is IFNA2; the disease is ovarian carcinoma.